Infectious Diseases

Kang D, Huang CX, Yuen AD, Norris KC, Vijayan T. Do hospitals that participate in COVID-19 research differ from non-trial hospitals? A cross-sectional study of[...]

By sjmartinez • August 8, 2023

Dovel K, Balakasi K, Phiri K, Shaba F, Offorjebe OA, Gupta SK, Wong V, Lungu E, Nichols BE, Masina T, Worku A, Hoffman R, Nyirenda[...]

By sjmartinez • August 5, 2023

Bhattacharya D, Tierney C, Butler K, Kiweewa FM, Moodley D, Govender V, Vhembo T, Mohtashemi N, Ship H, Dula D, George K, Chaktoura N, Fowler[...]

By sjmartinez • August 4, 2023

Huaman MA, Raval JS, Paxton JH, Mosnaim GS, Patel B, Anjan S, Meisenberg BR, Levine AC, Marshall CE, Yarava A, Shenoy AG, Heath SL, Currier[...]

By sjmartinez • August 4, 2023

Rubinstein PG, Moore PC, Bimali M, Lee JY, Rudek MA, Chadburn A, Ratner L, Henry DH, Cesarman E, DeMarco CE, Costagliola D, Taoufik Y, Ramos[...]

By sjmartinez • August 3, 2023

Haigentz M, Lee JY, Chiao EY, Aboulafia DM, Ratner L, Ambinder RF, Baiocchi RA, Mitsuyasu RT, Wachsman W, Sparano JA, Rudek MA. Phase I trial[...]

By sjmartinez • August 1, 2023

Cerón S, Salem-Bango Z, Contreras DA, Ranson EL, Yang S. Clinical and Genomic Characterization of Carbapenem-Resistant Klebsiella pneumoniae with Concurrent Production of NDM and OXA-48-like Carbapenemases in[...]

By sjmartinez • July 30, 2023

Turpin RE, Mandell CJ, Camp AD, Davidson Mhonde RR, Dyer TV, Mayer KH, Liu H, Coates T, Boekeloo BO. Monkeypox-Related Stigma and Vaccine Challenges as[...]

By sjmartinez • July 30, 2023

Chan LC, Lee HK, Wang L, Chaili S, Xiong YQ, Bayer AS, Proctor RA, Yeaman MR. Diflunisal and Analogue Pharmacophores Mediating Suppression of Virulence Phenotypes[...]

By sjmartinez • July 30, 2023

Mishra NN, de Paula Baptista R, Tran TT, Lapitan CK, Garcia-de-la-Maria C, Miró JM, Proctor RA, Bayer AS. Membrane Phenotypic, Metabolic and Genotypic Adaptations of Streptococcus[...]

By sjmartinez • July 30, 2023